Home » Topics » Regulatory » Patents

Patents
RSS

Synthelabo team presents new agents for incontinence

Nov. 3, 1998

Preparation and use of TNF-alpha and MMP inhibitors described by Novartis

Nov. 3, 1998

Suntory describes new series for cardio- and cerebrovascular and peripheral circulatory disorders

Nov. 3, 1998

PTK inhibitors described by Knoll for immune and bone diseases

Nov. 3, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

HMR presents new agents for lipid disorders

Nov. 2, 1998

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

Aminoacyl sulfamides synthesized at Cubist claimed for psoriasis

Nov. 2, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Camptothecin analogues and prodrugs described in patent literature by SCRAS

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...